Stocklytics Platform
Asset logo for symbol NTRA
Natera
NTRA71
$105.98arrow_drop_up4.77%$4.83
High Growth
Asset logo for symbol NTRA
NTRA71

$105.98

arrow_drop_up4.77%
Key Stats
Open$101.95
Prev. Close$101.15
EPS-3.11
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
PE Ratio-
LOWHIGH
Day Range101.40
107.46
52 Week Range36.90
117.23
Ratios
EPS-3.11
Fundamentals
Payout Ratio-
Industry average yield2.85%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell
Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

NTRAarrow_drop_up4.78%
US Healthcare Sectorarrow_drop_up0.51%
US Marketarrow_drop_down1.27%
check_circle
NTRA / Market
NTRA exceeded the US Market which returned -1.27% over the last twenty four hours.
check_circle
NTRA / Healthcare Sector
NTRA exceeded the US Healthcare sector which returned 0.51% over the last twenty four hours.

Natera (NTRA) Statistics

Founded in 2004, Natera Inc (NTRA) is a leading genetic testing and diagnostics company that specializes in reproductive health, oncology, and organ transplantation. The company utilizes advanced technologies, such as next-generation sequencing and single-nucleotide polymorphism (SNP) genotyping, to provide accurate and reliable genetic testing solutions. With a focus on improving patient outcomes, Natera offers a range of products and services, including non-invasive prenatal testing (NIPT), carrier screening, and liquid biopsy testing for cancer detection. These innovative solutions have positioned Natera as a trusted partner for physicians and patients worldwide.

Natera's strong financial performance is evident in its valuation metrics. As of the latest data, Natera Inc has a market capitalization of over $8 billion and a price-to-earnings (P/E) ratio of approximately -286. This negative P/E ratio reflects the company's current focus on growth and expansion rather than profitability. In terms of its fundamentals, Natera Inc recorded a revenue growth rate of 41% in the last quarter, demonstrating its ability to generate significant revenue despite the ongoing challenges in the healthcare industry. Additionally, Natera's Enterprise to EBITDA ratio stands at 33.1, indicating the company's ability to generate substantial earnings before interest, taxes, depreciation, and amortization.

add Natera  to watchlist

Keep an eye on Natera

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is the operating margin of Natera (NTRA) stock?

The operating margin for Natera (NTRA) is -20.21%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.

help
How has Natera (NTRA) stock's performance compared to its sector and the market over the past year?

Over the past year, Natera (NTRA) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 25.14%, Natera has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 50.54%, it has fallen short of the market average. This comparison highlights Natera 's performance relative to both its sector and the overall market over the last year.

help
What is the PE ratio of Natera (NTRA) stock?

The PE ratio for Natera (NTRA) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.

help
What is the EPS of Natera (NTRA) stock?

The Earnings Per Share (EPS) for Natera (NTRA), calculated on a diluted basis, is -$3.11. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.

help
What is the EBITDA of Natera (NTRA) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Natera (NTRA) is -$358.58M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.

help
How much debt does Natera (NTRA) have?

Natera (NTRA) has a total debt of $439.79M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$374.03M.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level